1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pharmaceutical Products and CMO Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Active Pharmaceutical Ingredient (API)
        1.2.3 Finished Dosage Form (FDF)
        1.2.4 Pharmaceutical Packaging
    1.3 Market by Application
        1.3.1 Global Pharmaceutical Products and CMO Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Specialty/Midsize
        1.3.3 Generics
        1.3.4 Big Pharma
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Pharmaceutical Products and CMO Market Perspective (2017-2028)
    2.2 Pharmaceutical Products and CMO Growth Trends by Region
        2.2.1 Pharmaceutical Products and CMO Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Pharmaceutical Products and CMO Historic Market Size by Region (2017-2022)
        2.2.3 Pharmaceutical Products and CMO Forecasted Market Size by Region (2023-2028)
    2.3 Pharmaceutical Products and CMO Market Dynamics
        2.3.1 Pharmaceutical Products and CMO Industry Trends
        2.3.2 Pharmaceutical Products and CMO Market Drivers
        2.3.3 Pharmaceutical Products and CMO Market Challenges
        2.3.4 Pharmaceutical Products and CMO Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Pharmaceutical Products and CMO Players by Revenue
        3.1.1 Global Top Pharmaceutical Products and CMO Players by Revenue (2017-2022)
        3.1.2 Global Pharmaceutical Products and CMO Revenue Market Share by Players (2017-2022)
    3.2 Global Pharmaceutical Products and CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Pharmaceutical Products and CMO Revenue
    3.4 Global Pharmaceutical Products and CMO Market Concentration Ratio
        3.4.1 Global Pharmaceutical Products and CMO Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Products and CMO Revenue in 2021
    3.5 Pharmaceutical Products and CMO Key Players Head office and Area Served
    3.6 Key Players Pharmaceutical Products and CMO Product Solution and Service
    3.7 Date of Enter into Pharmaceutical Products and CMO Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Products and CMO Breakdown Data by Type
    4.1 Global Pharmaceutical Products and CMO Historic Market Size by Type (2017-2022)
    4.2 Global Pharmaceutical Products and CMO Forecasted Market Size by Type (2023-2028)
5 Pharmaceutical Products and CMO Breakdown Data by Application
    5.1 Global Pharmaceutical Products and CMO Historic Market Size by Application (2017-2022)
    5.2 Global Pharmaceutical Products and CMO Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Pharmaceutical Products and CMO Market Size (2017-2028)
    6.2 North America Pharmaceutical Products and CMO Market Size by Type
        6.2.1 North America Pharmaceutical Products and CMO Market Size by Type (2017-2022)
        6.2.2 North America Pharmaceutical Products and CMO Market Size by Type (2023-2028)
        6.2.3 North America Pharmaceutical Products and CMO Market Share by Type (2017-2028)
    6.3 North America Pharmaceutical Products and CMO Market Size by Application
        6.3.1 North America Pharmaceutical Products and CMO Market Size by Application (2017-2022)
        6.3.2 North America Pharmaceutical Products and CMO Market Size by Application (2023-2028)
        6.3.3 North America Pharmaceutical Products and CMO Market Share by Application (2017-2028)
    6.4 North America Pharmaceutical Products and CMO Market Size by Country
        6.4.1 North America Pharmaceutical Products and CMO Market Size by Country (2017-2022)
        6.4.2 North America Pharmaceutical Products and CMO Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Pharmaceutical Products and CMO Market Size (2017-2028)
    7.2 Europe Pharmaceutical Products and CMO Market Size by Type
        7.2.1 Europe Pharmaceutical Products and CMO Market Size by Type (2017-2022)
        7.2.2 Europe Pharmaceutical Products and CMO Market Size by Type (2023-2028)
        7.2.3 Europe Pharmaceutical Products and CMO Market Share by Type (2017-2028)
    7.3 Europe Pharmaceutical Products and CMO Market Size by Application
        7.3.1 Europe Pharmaceutical Products and CMO Market Size by Application (2017-2022)
        7.3.2 Europe Pharmaceutical Products and CMO Market Size by Application (2023-2028)
        7.3.3 Europe Pharmaceutical Products and CMO Market Share by Application (2017-2028)
    7.4 Europe Pharmaceutical Products and CMO Market Size by Country
        7.4.1 Europe Pharmaceutical Products and CMO Market Size by Country (2017-2022)
        7.4.2 Europe Pharmaceutical Products and CMO Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Pharmaceutical Products and CMO Market Size (2017-2028)
    8.2 Asia-Pacific Pharmaceutical Products and CMO Market Size by Type
        8.2.1 Asia-Pacific Pharmaceutical Products and CMO Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Pharmaceutical Products and CMO Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Pharmaceutical Products and CMO Market Share by Type (2017-2028)
    8.3 Asia-Pacific Pharmaceutical Products and CMO Market Size by Application
        8.3.1 Asia-Pacific Pharmaceutical Products and CMO Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Pharmaceutical Products and CMO Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Pharmaceutical Products and CMO Market Share by Application (2017-2028)
    8.4 Asia-Pacific Pharmaceutical Products and CMO Market Size by Region
        8.4.1 Asia-Pacific Pharmaceutical Products and CMO Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Pharmaceutical Products and CMO Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Pharmaceutical Products and CMO Market Size (2017-2028)
    9.2 Latin America Pharmaceutical Products and CMO Market Size by Type
        9.2.1 Latin America Pharmaceutical Products and CMO Market Size by Type (2017-2022)
        9.2.2 Latin America Pharmaceutical Products and CMO Market Size by Type (2023-2028)
        9.2.3 Latin America Pharmaceutical Products and CMO Market Share by Type (2017-2028)
    9.3 Latin America Pharmaceutical Products and CMO Market Size by Application
        9.3.1 Latin America Pharmaceutical Products and CMO Market Size by Application (2017-2022)
        9.3.2 Latin America Pharmaceutical Products and CMO Market Size by Application (2023-2028)
        9.3.3 Latin America Pharmaceutical Products and CMO Market Share by Application (2017-2028)
    9.4 Latin America Pharmaceutical Products and CMO Market Size by Country
        9.4.1 Latin America Pharmaceutical Products and CMO Market Size by Country (2017-2022)
        9.4.2 Latin America Pharmaceutical Products and CMO Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Pharmaceutical Products and CMO Market Size (2017-2028)
    10.2 Middle East & Africa Pharmaceutical Products and CMO Market Size by Type
        10.2.1 Middle East & Africa Pharmaceutical Products and CMO Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Pharmaceutical Products and CMO Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Pharmaceutical Products and CMO Market Share by Type (2017-2028)
    10.3 Middle East & Africa Pharmaceutical Products and CMO Market Size by Application
        10.3.1 Middle East & Africa Pharmaceutical Products and CMO Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Pharmaceutical Products and CMO Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Pharmaceutical Products and CMO Market Share by Application (2017-2028)
    10.4 Middle East & Africa Pharmaceutical Products and CMO Market Size by Country
        10.4.1 Middle East & Africa Pharmaceutical Products and CMO Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Pharmaceutical Products and CMO Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Catalent
        11.1.1 Catalent Company Details
        11.1.2 Catalent Business Overview
        11.1.3 Catalent Pharmaceutical Products and CMO Introduction
        11.1.4 Catalent Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.1.5 Catalent Recent Developments
    11.2 DPx
        11.2.1 DPx Company Details
        11.2.2 DPx Business Overview
        11.2.3 DPx Pharmaceutical Products and CMO Introduction
        11.2.4 DPx Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.2.5 DPx Recent Developments
    11.3 Lonza
        11.3.1 Lonza Company Details
        11.3.2 Lonza Business Overview
        11.3.3 Lonza Pharmaceutical Products and CMO Introduction
        11.3.4 Lonza Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.3.5 Lonza Recent Developments
    11.4 Piramal Healthcare
        11.4.1 Piramal Healthcare Company Details
        11.4.2 Piramal Healthcare Business Overview
        11.4.3 Piramal Healthcare Pharmaceutical Products and CMO Introduction
        11.4.4 Piramal Healthcare Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.4.5 Piramal Healthcare Recent Developments
    11.5 Aenova
        11.5.1 Aenova Company Details
        11.5.2 Aenova Business Overview
        11.5.3 Aenova Pharmaceutical Products and CMO Introduction
        11.5.4 Aenova Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.5.5 Aenova Recent Developments
    11.6 Jubilant
        11.6.1 Jubilant Company Details
        11.6.2 Jubilant Business Overview
        11.6.3 Jubilant Pharmaceutical Products and CMO Introduction
        11.6.4 Jubilant Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.6.5 Jubilant Recent Developments
    11.7 Famar
        11.7.1 Famar Company Details
        11.7.2 Famar Business Overview
        11.7.3 Famar Pharmaceutical Products and CMO Introduction
        11.7.4 Famar Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.7.5 Famar Recent Developments
    11.8 Boehringer Ingelheim
        11.8.1 Boehringer Ingelheim Company Details
        11.8.2 Boehringer Ingelheim Business Overview
        11.8.3 Boehringer Ingelheim Pharmaceutical Products and CMO Introduction
        11.8.4 Boehringer Ingelheim Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.8.5 Boehringer Ingelheim Recent Developments
    11.9 Fareva Holding
        11.9.1 Fareva Holding Company Details
        11.9.2 Fareva Holding Business Overview
        11.9.3 Fareva Holding Pharmaceutical Products and CMO Introduction
        11.9.4 Fareva Holding Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.9.5 Fareva Holding Recent Developments
    11.10 AbbVie
        11.10.1 AbbVie Company Details
        11.10.2 AbbVie Business Overview
        11.10.3 AbbVie Pharmaceutical Products and CMO Introduction
        11.10.4 AbbVie Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.10.5 AbbVie Recent Developments
    11.11 Nipro Corp
        11.11.1 Nipro Corp Company Details
        11.11.2 Nipro Corp Business Overview
        11.11.3 Nipro Corp Pharmaceutical Products and CMO Introduction
        11.11.4 Nipro Corp Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.11.5 Nipro Corp Recent Developments
    11.12 Vetter
        11.12.1 Vetter Company Details
        11.12.2 Vetter Business Overview
        11.12.3 Vetter Pharmaceutical Products and CMO Introduction
        11.12.4 Vetter Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.12.5 Vetter Recent Developments
    11.13 Sopharma
        11.13.1 Sopharma Company Details
        11.13.2 Sopharma Business Overview
        11.13.3 Sopharma Pharmaceutical Products and CMO Introduction
        11.13.4 Sopharma Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.13.5 Sopharma Recent Developments
    11.14 Mylan (DPT Laboratories)
        11.14.1 Mylan (DPT Laboratories) Company Details
        11.14.2 Mylan (DPT Laboratories) Business Overview
        11.14.3 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Introduction
        11.14.4 Mylan (DPT Laboratories) Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.14.5 Mylan (DPT Laboratories) Recent Developments
    11.15 Recipharm
        11.15.1 Recipharm Company Details
        11.15.2 Recipharm Business Overview
        11.15.3 Recipharm Pharmaceutical Products and CMO Introduction
        11.15.4 Recipharm Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.15.5 Recipharm Recent Developments
    11.16 NextPharma Technologies
        11.16.1 NextPharma Technologies Company Details
        11.16.2 NextPharma Technologies Business Overview
        11.16.3 NextPharma Technologies Pharmaceutical Products and CMO Introduction
        11.16.4 NextPharma Technologies Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.16.5 NextPharma Technologies Recent Developments
    11.17 Dishman
        11.17.1 Dishman Company Details
        11.17.2 Dishman Business Overview
        11.17.3 Dishman Pharmaceutical Products and CMO Introduction
        11.17.4 Dishman Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.17.5 Dishman Recent Developments
    11.18 Aesica
        11.18.1 Aesica Company Details
        11.18.2 Aesica Business Overview
        11.18.3 Aesica Pharmaceutical Products and CMO Introduction
        11.18.4 Aesica Revenue in Pharmaceutical Products and CMO Business (2017-2022)
        11.18.5 Aesica Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Pharmaceutical Products and CMO Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Active Pharmaceutical Ingredient (API)
    Table 3. Key Players of Finished Dosage Form (FDF)
    Table 4. Key Players of Pharmaceutical Packaging
    Table 5. Global Pharmaceutical Products and CMO Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Pharmaceutical Products and CMO Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Pharmaceutical Products and CMO Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Pharmaceutical Products and CMO Market Share by Region (2017-2022)
    Table 9. Global Pharmaceutical Products and CMO Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Pharmaceutical Products and CMO Market Share by Region (2023-2028)
    Table 11. Pharmaceutical Products and CMO Market Trends
    Table 12. Pharmaceutical Products and CMO Market Drivers
    Table 13. Pharmaceutical Products and CMO Market Challenges
    Table 14. Pharmaceutical Products and CMO Market Restraints
    Table 15. Global Pharmaceutical Products and CMO Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Pharmaceutical Products and CMO Revenue Share by Players (2017-2022)
    Table 17. Global Top Pharmaceutical Products and CMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Products and CMO as of 2021)
    Table 18. Ranking of Global Top Pharmaceutical Products and CMO Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Pharmaceutical Products and CMO Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Pharmaceutical Products and CMO Product Solution and Service
    Table 22. Date of Enter into Pharmaceutical Products and CMO Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Pharmaceutical Products and CMO Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Pharmaceutical Products and CMO Revenue Market Share by Type (2017-2022)
    Table 26. Global Pharmaceutical Products and CMO Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Pharmaceutical Products and CMO Revenue Market Share by Type (2023-2028)
    Table 28. Global Pharmaceutical Products and CMO Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Pharmaceutical Products and CMO Revenue Share by Application (2017-2022)
    Table 30. Global Pharmaceutical Products and CMO Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Pharmaceutical Products and CMO Revenue Share by Application (2023-2028)
    Table 32. North America Pharmaceutical Products and CMO Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Pharmaceutical Products and CMO Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Pharmaceutical Products and CMO Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Pharmaceutical Products and CMO Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Pharmaceutical Products and CMO Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Pharmaceutical Products and CMO Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Pharmaceutical Products and CMO Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Pharmaceutical Products and CMO Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Pharmaceutical Products and CMO Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Pharmaceutical Products and CMO Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Pharmaceutical Products and CMO Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Pharmaceutical Products and CMO Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Pharmaceutical Products and CMO Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Pharmaceutical Products and CMO Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Pharmaceutical Products and CMO Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Pharmaceutical Products and CMO Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Pharmaceutical Products and CMO Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Pharmaceutical Products and CMO Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Pharmaceutical Products and CMO Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Pharmaceutical Products and CMO Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Pharmaceutical Products and CMO Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Pharmaceutical Products and CMO Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Pharmaceutical Products and CMO Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Pharmaceutical Products and CMO Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Pharmaceutical Products and CMO Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Pharmaceutical Products and CMO Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Pharmaceutical Products and CMO Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Pharmaceutical Products and CMO Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Pharmaceutical Products and CMO Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Pharmaceutical Products and CMO Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Catalent Company Details
    Table 63. Catalent Business Overview
    Table 64. Catalent Pharmaceutical Products and CMO Product
    Table 65. Catalent Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 66. Catalent Recent Developments
    Table 67. DPx Company Details
    Table 68. DPx Business Overview
    Table 69. DPx Pharmaceutical Products and CMO Product
    Table 70. DPx Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 71. DPx Recent Developments
    Table 72. Lonza Company Details
    Table 73. Lonza Business Overview
    Table 74. Lonza Pharmaceutical Products and CMO Product
    Table 75. Lonza Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 76. Lonza Recent Developments
    Table 77. Piramal Healthcare Company Details
    Table 78. Piramal Healthcare Business Overview
    Table 79. Piramal Healthcare Pharmaceutical Products and CMO Product
    Table 80. Piramal Healthcare Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 81. Piramal Healthcare Recent Developments
    Table 82. Aenova Company Details
    Table 83. Aenova Business Overview
    Table 84. Aenova Pharmaceutical Products and CMO Product
    Table 85. Aenova Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 86. Aenova Recent Developments
    Table 87. Jubilant Company Details
    Table 88. Jubilant Business Overview
    Table 89. Jubilant Pharmaceutical Products and CMO Product
    Table 90. Jubilant Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 91. Jubilant Recent Developments
    Table 92. Famar Company Details
    Table 93. Famar Business Overview
    Table 94. Famar Pharmaceutical Products and CMO Product
    Table 95. Famar Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 96. Famar Recent Developments
    Table 97. Boehringer Ingelheim Company Details
    Table 98. Boehringer Ingelheim Business Overview
    Table 99. Boehringer Ingelheim Pharmaceutical Products and CMO Product
    Table 100. Boehringer Ingelheim Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 101. Boehringer Ingelheim Recent Developments
    Table 102. Fareva Holding Company Details
    Table 103. Fareva Holding Business Overview
    Table 104. Fareva Holding Pharmaceutical Products and CMO Product
    Table 105. Fareva Holding Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 106. Fareva Holding Recent Developments
    Table 107. AbbVie Company Details
    Table 108. AbbVie Business Overview
    Table 109. AbbVie Pharmaceutical Products and CMO Product
    Table 110. AbbVie Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 111. AbbVie Recent Developments
    Table 112. Nipro Corp Company Details
    Table 113. Nipro Corp Business Overview
    Table 114. Nipro Corp Pharmaceutical Products and CMO Product
    Table 115. Nipro Corp Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 116. Nipro Corp Recent Developments
    Table 117. Vetter Company Details
    Table 118. Vetter Business Overview
    Table 119. Vetter Pharmaceutical Products and CMO Product
    Table 120. Vetter Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 121. Vetter Recent Developments
    Table 122. Sopharma Company Details
    Table 123. Sopharma Business Overview
    Table 124. Sopharma Pharmaceutical Products and CMO Product
    Table 125. Sopharma Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 126. Sopharma Recent Developments
    Table 127. Mylan (DPT Laboratories) Company Details
    Table 128. Mylan (DPT Laboratories) Business Overview
    Table 129. Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product
    Table 130. Mylan (DPT Laboratories) Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 131. Mylan (DPT Laboratories) Recent Developments
    Table 132. Recipharm Company Details
    Table 133. Recipharm Business Overview
    Table 134. Recipharm Pharmaceutical Products and CMO Product
    Table 135. Recipharm Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 136. Recipharm Recent Developments
    Table 137. NextPharma Technologies Company Details
    Table 138. NextPharma Technologies Business Overview
    Table 139. NextPharma Technologies Pharmaceutical Products and CMO Product
    Table 140. NextPharma Technologies Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 141. NextPharma Technologies Recent Developments
    Table 142. Dishman Company Details
    Table 143. Dishman Business Overview
    Table 144. Dishman Pharmaceutical Products and CMO Product
    Table 145. Dishman Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 146. Dishman Recent Developments
    Table 147. Aesica Company Details
    Table 148. Aesica Business Overview
    Table 149. Aesica Pharmaceutical Products and CMO Product
    Table 150. Aesica Revenue in Pharmaceutical Products and CMO Business (2017-2022) & (US$ Million)
    Table 151. Aesica Recent Developments
    Table 152. Research Programs/Design for This Report
    Table 153. Key Data Information from Secondary Sources
    Table 154. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pharmaceutical Products and CMO Market Share by Type: 2021 VS 2028
    Figure 2. Active Pharmaceutical Ingredient (API) Features
    Figure 3. Finished Dosage Form (FDF) Features
    Figure 4. Pharmaceutical Packaging Features
    Figure 5. Global Pharmaceutical Products and CMO Market Share by Application: 2021 VS 2028
    Figure 6. Specialty/Midsize Case Studies
    Figure 7. Generics Case Studies
    Figure 8. Big Pharma Case Studies
    Figure 9. Others Case Studies
    Figure 10. Pharmaceutical Products and CMO Report Years Considered
    Figure 11. Global Pharmaceutical Products and CMO Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Pharmaceutical Products and CMO Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Pharmaceutical Products and CMO Market Share by Region: 2021 VS 2028
    Figure 14. Global Pharmaceutical Products and CMO Market Share by Players in 2021
    Figure 15. Global Top Pharmaceutical Products and CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Products and CMO as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Pharmaceutical Products and CMO Revenue in 2021
    Figure 17. North America Pharmaceutical Products and CMO Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Pharmaceutical Products and CMO Market Size Market Share by Type (2017-2028)
    Figure 19. North America Pharmaceutical Products and CMO Market Size Market Share by Application (2017-2028)
    Figure 20. North America Pharmaceutical Products and CMO Market Size Share by Country (2017-2028)
    Figure 21. United States Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Pharmaceutical Products and CMO Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Pharmaceutical Products and CMO Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Pharmaceutical Products and CMO Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Pharmaceutical Products and CMO Market Size Share by Country (2017-2028)
    Figure 27. Germany Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Pharmaceutical Products and CMO Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Pharmaceutical Products and CMO Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Pharmaceutical Products and CMO Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Pharmaceutical Products and CMO Market Size Share by Region (2017-2028)
    Figure 37. China Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Pharmaceutical Products and CMO Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Pharmaceutical Products and CMO Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Pharmaceutical Products and CMO Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Pharmaceutical Products and CMO Market Size Share by Country (2017-2028)
    Figure 47. Mexico Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Pharmaceutical Products and CMO Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Pharmaceutical Products and CMO Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Pharmaceutical Products and CMO Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Pharmaceutical Products and CMO Market Size Share by Country (2017-2028)
    Figure 53. Turkey Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Pharmaceutical Products and CMO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Catalent Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 57. DPx Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 58. Lonza Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 59. Piramal Healthcare Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 60. Aenova Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 61. Jubilant Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 62. Famar Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 63. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 64. Fareva Holding Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 65. AbbVie Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 66. Nipro Corp Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 67. Vetter Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 68. Sopharma Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 69. Mylan (DPT Laboratories) Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 70. Recipharm Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 71. NextPharma Technologies Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 72. Dishman Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 73. Aesica Revenue Growth Rate in Pharmaceutical Products and CMO Business (2017-2022)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed